Document is current
Any future updates will be listed below
-
Authors
Chaba, Anis
Fodil, Sofiane
Lemiale, Virginie
Mariotte, Eric
Valade, Sandrine
Azoulay, Elie
Zafrani, Lara https://orcid.org/0000-0002-7805-3116
- License Information
-
More Information
Article History
Received: 20 July 2023
Accepted: 20 September 2023
First Online: 5 October 2023
Declarations
:
: This study was approved by an Institutional Review Board (IRB) (“Comité d’Evaluation de l’Ethique des projets de Recherche Biomédicale Paris Nord” (IRB 00006477- of Paris Cité University).
: According to the French regulation, the need for informed consent was waived. However, patients were informed that their data might be used for research purposes and none refused.
: L. Zafrani has received fees for lectures from MSD and Sanofi and her institution received a grant from Jazz Pharmaceuticals; E. Azoulay has received fees for lectures from MSD, Pfizer and Alexion. His institution and research group have received support from Baxter, Jazz Pharma, Fisher&Paykel, Gilead, Alexion and Ablynx. VL is treasurer of the GRRR-OH research group who received fees from Pfizer, Fisher-Paykel, Gilead, Astellas, Sanofi and, Alexion. EM reports consulting fees from SANOFI and Takeda. The remaining authors declare having nothing to disclose.
